Related Experiment Videos

Molecular cloning of a new human insulin-like growth factor binding protein

M C Kiefer1, R S Ioh, D M Bauer

  • 1Chiron Corporation, Emeryville, CA 94608.

Insights

Researchers cloned a novel insulin-like growth factor-binding protein (IGFBP) from human osteosarcoma cells. This new IGFBP shows significant homology to IGFBP-3, suggesting a role in bone cancer progression.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • Insulin-like growth factor-binding proteins (IGFBPs) play crucial roles in regulating IGF bioavailability.
  • Osteosarcoma is a primary bone cancer with complex molecular underpinnings.
  • Understanding novel IGFBP functions is vital for cancer research.

Purpose of the Study:

  • To identify and characterize a new IGFBP from human osteosarcoma.
  • To determine the sequence and structural features of the novel IGFBP.
  • To assess the homology of the new IGFBP to known IGFBP family members.

Main Methods:

  • Polymerase chain reaction (PCR) using degenerate primers based on conserved IGFBP regions.
  • Screening of a human osteosarcoma cDNA library.
  • DNA sequencing and amino acid sequence deduction.
  • Sequence homology analysis.

Main Results:

  • A unique IGFBP sequence was identified from PCR products.
  • Full-length cDNA clones of the novel IGFBP were isolated.
  • The deduced amino acid sequence revealed two potential signal peptidase cleavage sites.
  • The mature protein consists of 257 or 252 amino acids with 18 conserved cysteines.
  • Highest homology was observed with human IGFBP-3 (50% NH2-terminal, 45% COOH-terminal).

Conclusions:

  • A novel human IGFBP has been successfully cloned and sequenced.
  • The new IGFBP shares significant structural similarities with IGFBP-3.
  • Further studies are warranted to elucidate the specific functions of this novel IGFBP in osteosarcoma.

Related Concept Videos